HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors

Overview of attention for article published in Breast Cancer Research, March 2007

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 10 patents

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 75 Mendeley
citeulike: 2 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 10 patents that reference this research output.

Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272

Grant US-10729672-B2

United States of America

Method for treating gefitinib resistant cancer

Grant US-10603314-B2

United States of America

Method for treating gefitinib resistant cancer

Grant US-10596162-B2

United States of America

Antineoplastic combinations containing HKI-272 and vinorelbine

Grant US-10111868-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 6 additional patents.